➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Boehringer Ingelheim
AstraZeneca
Colorcon
Mallinckrodt

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

MOBIC Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Mobic patents expire, and when can generic versions of Mobic launch?

Mobic is a drug marketed by Avondale Pharms and Boehringer Ingelheim and is included in two NDAs.

The generic ingredient in MOBIC is meloxicam. There are twenty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the meloxicam profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Mobic

A generic version of MOBIC was approved as meloxicam by CIPLA on July 19th, 2006.

  Get Started for $10

Paragraph IV (Patent) Challenges for MOBIC
Tradename Dosage Ingredient NDA Submissiondate
MOBIC SUSPENSION;ORAL meloxicam 021530 2009-12-17

US Patents and Regulatory Information for MOBIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avondale Pharms MOBIC meloxicam SUSPENSION;ORAL 021530-001 Jun 1, 2004 DISCN Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Boehringer Ingelheim MOBIC meloxicam TABLET;ORAL 020938-001 Apr 13, 2000 AB RX Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Boehringer Ingelheim MOBIC meloxicam TABLET;ORAL 020938-002 Aug 23, 2000 AB RX Yes Yes   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Medtronic
Express Scripts
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.